103.89
전일 마감가:
$103.63
열려 있는:
$103.16
하루 거래량:
190.88K
Relative Volume:
0.12
시가총액:
$20.63B
수익:
$7.60B
순이익/손실:
$1.08B
주가수익비율:
19.75
EPS:
5.26
순현금흐름:
$1.26B
1주 성능:
+3.46%
1개월 성능:
-5.90%
6개월 성능:
-7.25%
1년 성능:
-18.97%
짐머 바이오메트 Stock (ZBH) Company Profile
명칭
Zimmer Biomet Holdings Inc
전화
(574) 267-6131
주소
345 EAST MAIN STREET, WARSAW, IN
ZBH을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ZBH
Zimmer Biomet Holdings Inc
|
103.93 | 20.63B | 7.60B | 1.08B | 1.26B | 5.26 |
![]()
ABT
Abbott Laboratories
|
134.34 | 230.98B | 41.95B | 13.40B | 6.49B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
105.33 | 155.49B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
385.51 | 147.45B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
89.67 | 112.85B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
73.98 | 44.06B | 5.72B | 4.17B | 490.10M | 6.97 |
짐머 바이오메트 Stock (ZBH) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
2024-09-10 | 개시 | Wolfe Research | Peer Perform |
2024-07-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2024-05-30 | 개시 | Goldman | Neutral |
2024-05-21 | 업그레이드 | Argus | Hold → Buy |
2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
2023-10-20 | 개시 | ROTH MKM | Neutral |
2023-08-28 | 업그레이드 | BTIG Research | Neutral → Buy |
2023-05-03 | 업그레이드 | BofA Securities | Underperform → Neutral |
2023-04-11 | 업그레이드 | Evercore ISI | In-line → Outperform |
2023-03-31 | 업그레이드 | Jefferies | Underperform → Hold |
2023-03-29 | 개시 | UBS | Sell |
2023-03-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
2023-01-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
2023-01-05 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
2022-11-23 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
2022-10-18 | 개시 | Barclays | Underweight |
2022-10-12 | 개시 | Jefferies | Underperform |
2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
2022-04-01 | 다운그레이드 | Citigroup | Buy → Neutral |
2022-03-02 | 재개 | BofA Securities | Underperform |
2022-03-02 | 다운그레이드 | Loop Capital | Buy → Hold |
2022-02-08 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
2022-02-08 | 재확인 | Citigroup | Buy |
2022-02-08 | 재확인 | Deutsche Bank | Hold |
2022-02-08 | 재확인 | JMP Securities | Mkt Outperform |
2022-02-08 | 재확인 | JP Morgan | Neutral |
2022-02-08 | 재확인 | RBC Capital Mkts | Sector Perform |
2022-02-08 | 재확인 | Stifel | Buy |
2022-02-08 | 재확인 | Truist | Buy |
2022-02-08 | 재확인 | UBS | Neutral |
2022-02-08 | 재확인 | Wells Fargo | Underweight |
2022-02-02 | 다운그레이드 | UBS | Buy → Neutral |
2022-01-19 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
2022-01-10 | 다운그레이드 | Mizuho | Buy → Neutral |
2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2021-12-10 | 개시 | RBC Capital Mkts | Sector Perform |
2021-12-09 | 다운그레이드 | Needham | Strong Buy → Buy |
2021-12-07 | 개시 | Loop Capital | Buy |
2021-11-23 | 다운그레이드 | Argus | Buy → Hold |
2021-09-14 | 재개 | Raymond James | Mkt Perform |
2021-05-25 | 개시 | Barclays | Overweight |
2021-04-09 | 업그레이드 | Northland Capital | Market Perform → Outperform |
2021-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
2020-12-18 | 재확인 | Needham | Strong Buy |
2020-10-20 | 개시 | Northland Capital | Market Perform |
2020-09-11 | 개시 | Wolfe Research | Outperform |
2020-08-05 | 재확인 | Needham | Strong Buy |
2020-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
2020-04-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
2020-04-07 | 재확인 | Needham | Strong Buy |
2020-03-05 | 개시 | Citigroup | Buy |
2020-02-13 | 개시 | Goldman | Buy |
2020-01-08 | 개시 | SunTrust | Buy |
2020-01-07 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
2020-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
2019-12-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2019-10-07 | 업그레이드 | BTIG Research | Neutral → Buy |
2019-09-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
2019-08-12 | 업그레이드 | Argus | Hold → Buy |
2019-07-30 | 업그레이드 | Barclays | Underweight → Equal Weight |
2019-07-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
2019-06-11 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
2019-04-24 | 업그레이드 | Needham | Buy → Strong Buy |
모두보기
짐머 바이오메트 주식(ZBH)의 최신 뉴스
Weil Advises Underwriters on Zimmer Biomet’s $1.75 Billion Notes Offering - Weil, Gotshal & Manges LLP
Zimmer Biomet issues new notes, details merger agreement terms - Investing.com
Zimmer Biomet issues new notes, details merger agreement terms By Investing.com - Investing.com UK
This Zimmer Biomet Holdings Insider Reduced Their Stake By 71% - Simply Wall St
Zimmer Biomet's SWOT analysis: medical device maker's stock faces ERP hurdles - MSN
Hourglass Capital LLC Has $7.12 Million Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Are Wall Street Analysts Predicting Zimmer Biomet Stock Will Climb or Sink? - MSN
Zimmer Biomet's SWOT analysis: stock outlook amid ERP challenges, market expansion - Investing.com Nigeria
Zimmer Biomet enters a distribution agreement with Promamec in Morocco - ZAWYA
Rhumbline Advisers Reduces Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
ZBH Stock Hurt by Margin Concerns and Difficult Solvency - Yahoo Finance
AlphaCentric Advisors LLC Makes New $623,000 Investment in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
74,083 Shares in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Acquired by KLCM Advisors Inc. - MarketBeat
Legacy Capital Wealth Partners LLC Makes New Investment in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Chevy Chase Trust Holdings LLC Trims Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
New York State Teachers Retirement System Has $17.82 Million Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
MFG Wealth Management Inc. Acquires Shares of 14,259 Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet price target lowered to $111 from $122 at Bernstein - MSN
Van ECK Associates Corp Buys 218,688 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
4,201 Shares in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Purchased by Roman Butler Fullerton & Co. - MarketBeat
103,508 Shares in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Bought by Strategic Financial Concepts LLC - MarketBeat
Zimmer Biomet (NYSE:ZBH) Hits New 12-Month LowTime to Sell? - MarketBeat
Allspring Global Investments Holdings LLC Trims Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
State of Alaska Department of Revenue Sells 6,280 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Purchases 22,396 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Barclays Lowers Zimmer Biomet (NYSE:ZBH) Price Target to $112.00 - MarketBeat
Brokers Set Expectations for Zimmer Biomet Q1 Earnings - MarketBeat
Zimmer Biomet's (ZBH) Hold Rating Reaffirmed at Truist Financial - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Position Lifted by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Paragon 28 : Zimmer Biomet Announces Definitive Agreement to Acquire Paragon 28 - Marketscreener.com
Biomaterial Coating Market Expected to Hit by 2032 | Emerging Technologies & Growth Analysis | Royal DSM, - EIN News
Live Oak Private Wealth LLC Decreases Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Orthopedic Implants Market worth $26.47 billion by 2029 -February 11, 2025 at 04:02 am EST - Marketscreener.com
Zimmer Biomet (NYSE:ZBH) Receives Hold Rating from Needham & Company LLC - MarketBeat
Orthopedic Implants Market worth $26.47 billion by 2029 - The Globe and Mail
Zimmer Biomet Holdings Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) - Benzinga
Zimmer Biomet (NYSE:ZBH) Shares Gap DownTime to Sell? - MarketBeat
Spinal Implants Market to Grow by USD 3.55 Billion from 2025-2029, Driven by Rising Spinal Disorder Prevalence, AI's Impact on Market TrendsTechnavio - The Malaysian Reserve
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q4 2024 Earnings Call Transcript - MSN
Zimmer Biomet (NYSE:ZBH) Issues FY 2025 Earnings Guidance - MarketBeat
Zimmer Biomet projects 3%-5% revenue growth for 2025 with over 50 product launches in 36 months - MSN
Zimmer Biomet net sales increase 4.3% to USD 2.023 bn in Q4 2024 - Medical Buyer
Zimmer Biomet slips as outlook misses consensus - MSN
Zimmer Biomet (ZBH) Surpasses Q4 Earnings and Revenue Estimates - MSN
Zimmer Biomet’s Strategic Growth Amid Challenges - TipRanks
짐머 바이오메트 (ZBH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):